Which of the following statements is false regarding the use of omalizumab (Xolair)?
A. Its use is recommended for patients with mild persistent asthma to prevent asthma flares.
B. The medication selectively binds to IgE to reduce exacerbations.
C. Labeled indication is for patients with poorly controlled asthma with frequent exacerbations.
D. Special evaluation is required prior to its use and ongoing monitoring is needed during use.
Answer: A. Its use is recommended for patients with mild persistent asthma to prevent asthma flares.
You might also like to view...
A 12-year-old child is being admitted to the unit for a surgical procedure. The child is accompanied by two parents and a younger sibling. The level of involvement in treatment decision making for this child is:
1. That of an emancipated minor. 2. That of a mature minor. 3. That of assent. 4. None.
What are the benefits of data integration? Select all that apply
1. Potential for improved remote access of clinical data from various systems 2. Trend analysis of financial and clinical data 3. Encouraging the use of systems customized to meet department specifications 4. Development of a computer-based patient record 5. Facilitation of data collection for accreditation purposes
A female patient sobs uncontrollably when talking about the recent death of a pet. Which response should the nurse implement to best provide for her immediate needs?
a. Sit with the patient quietly and allow her to cry. b. Provide tissues and promise to come back later. c. Ask why the patient is upset over the pet's death. d. Encourage her to describe the day she got her pet.
Which drug would be used to treat a child who has increased intracranial pressure (ICP) resulting from cerebral edema?
a. Mannitol c. Atropine sulfate b. Epinephrine hydrochloride d. Sodium bicarbonate